SAREPTA THERAPEUTICS INC (SRPT) Stock Price & Overview

NASDAQ:SRPT • US8036071004

16.205 USD
+0.33 (+2.11%)
Last: Mar 4, 2026, 02:41 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

The current stock price of SRPT is 16.205 USD. Today SRPT is up by 2.11%. In the past month the price decreased by -23.41%. In the past year, price decreased by -84.6%.

SRPT Key Statistics

52-Week Range10.415 - 103.316
Current SRPT stock price positioned within its 52-week range.
1-Month Range15.75 - 21.355
Current SRPT stock price positioned within its 1-month range.
Market Cap
1.701B
P/E
N/A
Fwd P/E
5.37
EPS (TTM)
-6.65
Dividend Yield
N/A

SRPT Stock Performance

Today
+2.11%
1 Week
-15.76%
1 Month
-23.41%
3 Months
-28.71%
Longer-term
6 Months -15.18%
1 Year -84.60%
2 Years -87.74%
3 Years -88.49%
5 Years -78.71%
10 Years -18.70%

SRPT Stock Chart

SAREPTA THERAPEUTICS INC / SRPT Daily stock chart

SRPT Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to SRPT. When comparing the yearly performance of all stocks, SRPT is a bad performer in the overall market: 95.97% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
SRPT Full Technical Analysis Report

SRPT Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to SRPT. SRPT has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
SRPT Full Fundamental Analysis Report

SRPT Earnings

On February 25, 2026 SRPT reported an EPS of -3.93 and a revenue of 442.93M. The company missed EPS expectations (-213.05% surprise) and beat revenue expectations (10.8% surprise).

Next Earnings DateMay 4, 2026
Last Earnings DateFeb 25, 2026
PeriodQ4 / 2025
EPS Reported-$3.93
Revenue Reported442.934M
EPS Surprise -213.05%
Revenue Surprise 10.80%
SRPT Earnings History

SRPT Forecast & Estimates

33 analysts have analysed SRPT and the average price target is 30.93 USD. This implies a price increase of 90.84% is expected in the next year compared to the current price of 16.205.

For the next year, analysts expect an EPS growth of 145.42% and a revenue growth -20.22% for SRPT


Analysts
Analysts67.27
Price Target30.93 (90.87%)
EPS Next Y145.42%
Revenue Next Year-20.22%
SRPT Forecast & Estimates

SRPT Groups

Sector & Classification

Sub-Industry
Biotechnology

SRPT Financial Highlights

Over the last trailing twelve months SRPT reported a non-GAAP Earnings per Share(EPS) of -6.65. The EPS decreased by -391.67% compared to the year before.


Income Statements
Revenue(TTM)2.20B
Net Income(TTM)-271.51M
Industry RankSector Rank
PM (TTM) N/A
ROA -7.77%
ROE -20.57%
Debt/Equity 0.78
Chartmill High Growth Momentum
EPS Q2Q%-362%
Sales Q2Q%-32.73%
EPS 1Y (TTM)-391.67%
Revenue 1Y (TTM)15.58%
SRPT financials

SRPT Ownership

Ownership
Inst Owners84.9%
Shares104.96M
Float99.15M
Ins Owners5.13%
Short Float %22.39%
Short Ratio8.11
SRPT Ownership

SRPT Latest News, Press Relases and Analysis

7 days ago - By: Chartmill
All SRPT news

SRPT Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
ABBV ABBVIE INC16.23413.319B
AMGN AMGEN INC16.83203.007B
GILD GILEAD SCIENCES INC16.64183.41B
VRTX VERTEX PHARMACEUTICALS INC23.49120.332B
REGN REGENERON PHARMACEUTICALS16.9681.051B
ALNY ALNYLAM PHARMACEUTICALS INC48.6642.097B
INSM INSMED INC N/A31.351B
NTRA NATERA INC N/A29.344B
BIIB BIOGEN INC12.4427.007B
UTHR UNITED THERAPEUTICS CORP16.3521.856B
RVMD REVOLUTION MEDICINES INC N/A19.914B
EXAS EXACT SCIENCES CORP309.3819.724B
MRNA MODERNA INC N/A19.468B

Related stock screener links

View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges

About SRPT

Company Profile

SRPT logo image The company is headquartered in Cambridge, Massachusetts.

Company Info

SAREPTA THERAPEUTICS INC

215 First Street, Suite 415

Cambridge MASSACHUSETTS 02142 US

CEO: Douglas S. Ingram

Employees: 1372

SRPT Company Website

SRPT Investor Relations

Phone: 16172744000

SAREPTA THERAPEUTICS INC / SRPT FAQ

What does SAREPTA THERAPEUTICS INC do?

The company is headquartered in Cambridge, Massachusetts.


Can you provide the latest stock price for SAREPTA THERAPEUTICS INC?

The current stock price of SRPT is 16.205 USD. The price increased by 2.11% in the last trading session.


Does SRPT stock pay dividends?

SRPT does not pay a dividend.


How is the ChartMill rating for SAREPTA THERAPEUTICS INC?

SRPT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Can you provide the growth outlook for SAREPTA THERAPEUTICS INC?

The Revenue of SAREPTA THERAPEUTICS INC (SRPT) is expected to decline by -20.22% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


What is SAREPTA THERAPEUTICS INC worth?

SAREPTA THERAPEUTICS INC (SRPT) has a market capitalization of 1.70B USD. This makes SRPT a Small Cap stock.


What is the Short Interest ratio of SAREPTA THERAPEUTICS INC (SRPT) stock?

The outstanding short interest for SAREPTA THERAPEUTICS INC (SRPT) is 22.39% of its float.